Meeting Banner
Abstract #3665

23Na-MRI demonstrates a sodium gradient within gliomas as a biomarker of tumor heterogeneity

Fulvio Zaccagna1, Frank Riemer1, Mary A McLean2, James T. Grist1, Joshua Kaggie1, Rolf Schulte3, Sarah Hilborne1, Tomasz Matys1, Jonathan H. Gillard1, Colin Watts4, Stephen J. Price4, Martin J. Graves1, and Ferdia A. Gallagher1

1Department of Radiology, University of Cambridge, Cambridge, United Kingdom, 2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom, 3GE Global Research, Munich, Germany, 4Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom

Glioma grade and the extent of local infiltration are important for guiding management. Imaging tumor heterogeneity may improve diagnosis and therapy planning. 23Na-MRI has been used here to demonstrate a gradient in sodium concentration across gliomas: necrosis > viable tissue > edema. This gradient was evident in all the tumors analyzed and is consistent with the expected underlying cellular microstructure where the sodium concentration is dominated by the extracellular fluid in edema and by an absence of cells in the necrotic core. The study provides evidence that 23Na-MRI represents an imaging biomarker of tumor heterogeneity and tissue microstructure in glioma.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords